Home/Filings/4/0001628280-25-000232
4//SEC Filing

Hansen Carl L. G. 4

Accession 0001628280-25-000232

CIK 0001703057other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 3:36 PM ET

Size

5.6 KB

Accession

0001628280-25-000232

Insider Transaction Report

Form 4
Period: 2025-01-01
Hansen Carl L. G.
DirectorChief Executive Officer10% Owner
Transactions
  • Award

    Share option (right to buy)

    2025-01-01+2,730,10910,990,332 total
    Exercise: $2.93Exp: 2035-01-01Common Shares (2,730,109 underlying)
Footnotes (1)
  • [F1]The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date

Issuer

AbCellera Biologics Inc.

CIK 0001703057

Entity typeother

Related Parties

1
  • filerCIK 0001834412

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 3:36 PM ET
Size
5.6 KB